Computational Design of Epitope-Specific Functional Antibodies
Guy Nimrod,
Sharon Fischman,
Mark Austin,
Asael Herman,
Feenagh Keyes,
Olga Leiderman,
David Hargreaves,
Marek Strajbl,
Jason Breed,
Shelley Klompus,
Kevin Minton,
Jennifer Spooner,
Andrew Buchanan,
Tristan J. Vaughan,
Yanay Ofran
Affiliations
Guy Nimrod
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
Sharon Fischman
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
Mark Austin
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Asael Herman
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
Feenagh Keyes
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Olga Leiderman
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
David Hargreaves
AstraZeneca R&D, Darwin Building Cambridge Science Park, Milton Road, Cambridge CB4 0WG, UK
Marek Strajbl
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
Jason Breed
AstraZeneca R&D, Darwin Building Cambridge Science Park, Milton Road, Cambridge CB4 0WG, UK
Shelley Klompus
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel
Kevin Minton
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Jennifer Spooner
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Andrew Buchanan
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Tristan J. Vaughan
Antibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge CB21 6GH, UK
Yanay Ofran
Biolojic Design, Ltd., 12 Hamada Street, Rehovot 7670314, Israel; The Goodman Faculty of Life Sciences, Nanotechnology Building, Bar Ilan University, Ramat Gan 52900, Israel; Corresponding author
Summary: The ultimate goal of protein design is to introduce new biological activity. We propose a computational approach for designing functional antibodies by focusing on functional epitopes, integrating large-scale statistical analysis with multiple structural models. Machine learning is used to analyze these models and predict specific residue-residue contacts. We use this approach to design a functional antibody to counter the proinflammatory effect of the cytokine interleukin-17A (IL-17A). X-ray crystallography confirms that the designed antibody binds the targeted epitope and the interaction is mediated by the designed contacts. Cell-based assays confirm that the antibody is functional. Importantly, this approach does not rely on a high-quality 3D model of the designed complex or even a solved structure of the target. As demonstrated here, this approach can be used to design biologically active antibodies, removing some of the main hurdles in antibody design and in drug discovery. : Nimrod et al. present an approach to computational design of epitope-specific antibodies. Using in silico methods targeting a chosen epitope, a functional antibody to IL-17A was engineered. The antibody binds IL-17A at the targeted epitope. A machine learning classifier predicts functionally relevant contacts between antigen and antibody. Keywords: antibody design, in silico protein design, IL-17A, protein modeling